Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
BengBu Medical College, Bengbu, Anhui, China.
Orphanet J Rare Dis. 2023 May 12;18(1):115. doi: 10.1186/s13023-023-02710-9.
The pathogenic variants responsible for Birt-Hogg-Dubé syndrome (BHDS) in folliculin (FLCN) gene mostly consist of point mutations. Although large intragenic deletions/duplications have been reported in several case reports, the relationship between large intragenic deletions/duplications and phenotype in BHDS remains unclear.
We retrospectively identified and reviewed patients with a large intragenic deletion spanning exons 1-3 and analyzed their phenotypic features to compare with those of point mutation carriers in our hospital from January 1, 2017 to August 31, 2022.
Twenty unique point mutations (including 4 novel mutations) were detected in 62 patients from 45 families (90%). Exons 1-3 deletion were identified in 8 patients from 5 families (10%) that resided in the same region, Feidong County of Anhui Province, China. Breakpoint analysis indicated that all the deletion breakpoints were flanked by Alu repeats. The prevalence of exons 1-3 deletion carriers in Feidong County was 8.1-times higher than that for BHDS in Anhui Province, suggesting a clustered phenomenon of exons 1-3 deletion. Significantly increased risk of pneumothorax was observed in those with exons 1-3 deletion compared with point mutations (91% vs. 58%, p value 0.047). The risk of renal cancer may be higher in those with exons 1-3 deletion than for those with point mutations (18% vs. 4%, p > 0.05).
Large intragenic deletion of exons 1-3 in FLCN was identified as a local aggregation phenomenon in Feidong County, China, and was associated with a significantly higher risk of pneumothorax compared to those with point mutations.
导致滤泡瘤素(FLCN)基因突变的 Birt-Hogg-Dubé 综合征(BHDS)的致病变体主要由点突变组成。尽管已有几例报道了较大的基因内缺失/重复,但 BHDS 中较大的基因内缺失/重复与表型之间的关系仍不清楚。
我们回顾性地鉴定并分析了一个跨越外显子 1-3 的基因内大片段缺失的患者,并分析了他们的表型特征,以与 2017 年 1 月 1 日至 2022 年 8 月 31 日期间在我院的点突变携带者进行比较。
在 45 个家庭的 62 名患者中发现了 20 个独特的点突变(包括 4 个新突变)。在来自中国安徽肥东县的 5 个家庭的 8 名患者中发现了外显子 1-3 的缺失。断裂点分析表明,所有缺失的断裂点都被 Alu 重复序列包围。肥东县外显子 1-3 缺失携带者的患病率比安徽省 BHDS 的患病率高 8.1 倍,表明外显子 1-3 缺失存在聚集现象。与点突变相比,外显子 1-3 缺失患者气胸的风险显著增加(91% vs. 58%,p 值 0.047)。与点突变相比,外显子 1-3 缺失患者患肾癌的风险可能更高(18% vs. 4%,p>0.05)。
FLCN 外显子 1-3 内的大片段缺失被鉴定为中国肥东县的局部聚集现象,与点突变相比,气胸的风险显著增加。